- About
- Programs
- News
- Careers
- Contact
- Home
News Archive
2009
26 November, 2009
ELARA Pharmaceuticals receives EUR 4.6
Million funding and names Dr. Christof Antz as Chief Business Officer.
Financing supports development of lead candidate for the treatment of Multiple
Myeloma and other cancers to IND.
ELARA Pharmaceuticals erhält Finanzierung
in Höhe von 4,6 Millionen Euro und ernennt Dr. Christof Antz zum Chief
Business Officer
Finanzmittel ermöglichen die Entwicklung eines innovativen Medikamentenkandidaten
zur Behandlung des Multiplen Myeloms und anderer Krebserkrankungen bis zur
Klinik.
• Elara Pharmaceuticals Presents at 2009 BIO International Convention
Heidelberg, May 14, 2009
CEO Joe Lewis presented at the 2009 BIO International Convention at the Georgia
International Convention Center in Atlanta, Georgia, May 20th at 10:20 AM
in Room 311 of Building A, Level 3
• Elara Pharmaceuticals Presents at BIO Equity Europe,
Heidelberg, May 14, 2009
CEO Joe Lewis presented at the 2009 BIO Equity Europe at the Hilton Munich Park Hotel, Munich, Germany, June 9th at 17:10 AM in Ballroom 2
• CHE Manager; ELARA_Spitzencluster
• Förderung: Aus dem Labor in die Wirtschaft: GO-Bio macht Biowissenschaftler zu Unternehmern
• EMBL /ELARA joint press release, 09 August, 2006
• Start-up Elara formed to develop anticancer drugs
• Elara Pharmaceuticals GmbH provides a fast track from bench to clinical application